Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935241 · ClinicalTrials.gov registry record · NA
mPATH for Low-income Older Adults
A NA study of Insomnia and Cognitive Decline, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT05935241: Recruiting NA study of Insomnia and Cognitive Decline, sponsored by Johns Hopkins University.
NCT05935241 is a NA study of Insomnia and Cognitive Decline that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 176 participants, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05935241, a NA study of Insomnia and Cognitive Decline, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
Although empirical research suggests that physical activity interventions benefit cognition and sleep in older adults in general, the possible benefit of physical activity is understudied in low-income older adults. The study aims to test the immediate and sustaining efficacy of an mHealth-facilitated Physical Activity Toward Health (mPATH) intervention on cognitive function and sleep in low-income older adults.
Primary Outcome
Episodic memory will be measured by computerized cognitive batteries using Cogstate
Conditions Studied
Interventions
- BEHAVIORAL mPATH
- OTHER Attention Control
Study Locations (1)
Maryland
- The Johns Hopkins University, School of Nursing - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT05935241 shows while recruiting
NCT05935241 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target.
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which mPATH is the first listed.
NCT05935241 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05935241 about?
NCT05935241 is a clinical study titled "mPATH for Low-income Older Adults". Although empirical research suggests that physical activity interventions benefit cognition and sleep in older adults in general, the possible benefit of physical activity is understudied in low-income older adults. The study aims to test the immediate and sustaining efficacy of an mHealth-facilitat...
What is the current status of trial NCT05935241?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2024-05-30. Estimated completion is 2029-12-31.
What conditions does trial NCT05935241 study?
This clinical trial studies the following conditions: Insomnia, Cognitive Decline, Sedentary Time.
What interventions are being tested in trial NCT05935241?
The interventions under investigation include: mPATH (BEHAVIORAL), Attention Control (OTHER).
Who is sponsoring clinical trial NCT05935241?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05935241 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05935241's enrollment target sits among peer trials
176 40th of 151 higher than 112 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI